| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P2093 | author name string | Otis W Brawley | |
| Colin B Begg | |||
| Deborah Schrag | |||
| Peter B Bach | |||
| Sofia Yakren | |||
| Aaron Galaznik | |||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cancer diagnosis | Q110324059 |
| P304 | page(s) | 2106-2113 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Survival of blacks and whites after a cancer diagnosis. | |
| P478 | volume | 287 |
| Q33280428 | A mammography database and view system for African-American patients. |
| Q36971869 | A new approach to understanding racial disparities in prostate cancer treatment |
| Q46871475 | A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma |
| Q35157688 | Access to hematopoietic stem cell transplantation: effect of race and sex. |
| Q55456781 | Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014. |
| Q28393814 | Adult brain cancer in the U.S. black population: a Surveillance, Epidemiology, and End Results (SEER) analysis of incidence, survival, and trends |
| Q37290523 | African American Race is an Independent Risk Factor in Survival from Initially Diagnosed Localized Breast Cancer |
| Q34998611 | African American women's perceptions of cancer clinical trials. |
| Q31138436 | African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. |
| Q44563417 | Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus |
| Q46158884 | Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center |
| Q44407580 | Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival |
| Q34116685 | Are risk factors for breast cancer associated with follow-up procedures in diverse women with abnormal mammography? |
| Q37537314 | Attitudes toward participation in breast cancer randomized clinical trials in the African American community: a focus group study |
| Q37002937 | Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review |
| Q47609738 | Becky's legacy: personal and professional reflections on loss and hope |
| Q35836218 | Black and white patients fare equally well when treated with postlumpectomy radiotherapy. |
| Q34095867 | Breast Cancer in Low and Middle Income Countries: How Can Guidelines Best Be Disseminated and Implemented? |
| Q37294917 | Breast and prostate cancer survival in Michigan: can geographic analyses assist in understanding racial disparities? |
| Q64123507 | Cancer Site-Specific Disparities in New York, Including the 1945-1965 Birth Cohort's Impact on Liver Cancer Patterns |
| Q37272646 | Cancer and disparities in health: perspectives on health statistics and research questions |
| Q59200904 | Cancer screening among jail inmates: frequency, knowledge, and willingness |
| Q39972544 | Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities |
| Q47191906 | Cancer statistics, 2018. |
| Q34798041 | Cancer survival in five continents: a worldwide population-based study (CONCORD). |
| Q48686500 | Cancer-related chronic pain: examining quality of life in diverse cancer survivors |
| Q37426645 | Cancer-specific beliefs and survival in nonmetastatic colorectal cancer patients |
| Q46613804 | Challenges of illness in metastatic breast cancer: a low-income African American perspective |
| Q38808040 | Challenges with in vitro and in vivo experimental models of urinary bladder cancer for novel drug discovery. |
| Q40093248 | Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer |
| Q38014541 | Chronic lymphocytic leukemia in African Americans |
| Q39843433 | Clinical Characteristics and Presentation of Lung Cancer According to Race and Place of Birth |
| Q35382759 | Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemia: joint experience of the MD Anderson Cancer Center and Duke University Medical Center |
| Q46922766 | Colon cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study |
| Q37578721 | Colorectal cancer disparities: issues, controversies and solutions |
| Q33387054 | Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems |
| Q40368173 | Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations |
| Q36875841 | Contemporary trends in necrotizing soft-tissue infections in the United States. |
| Q36493434 | Contribution of screening and survival differences to racial disparities in colorectal cancer rates |
| Q30539675 | Cost of comprehensive patient assistance program in early breast cancer patients |
| Q40537482 | Determinants of Survival for Adolescents and Young Adults with Urothelial Bladder Cancer: Results from the California Cancer Registry |
| Q36187658 | Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white Americans |
| Q34020931 | Discovery and validation of methylation markers for endometrial cancer |
| Q36965877 | Disentangling the effects of race on breast cancer treatment |
| Q37000419 | Disparate molecular, histopathology, and clinical factors in head and neck squamous cell carcinoma racial groups |
| Q39040422 | Disparities in Obesity, Physical Activity Rates, and Breast Cancer Survival. |
| Q61771806 | Disparities in Whites’ Versus Blacks’ Self-Rated Health: Social Status, Health-Care Services, and Health Behaviors |
| Q37962703 | Disparities in bladder cancer |
| Q37191364 | Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research |
| Q37304231 | Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis |
| Q88235295 | Disparities in genetics assessment for women with ovarian cancer: Can we do better? |
| Q44938677 | Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention |
| Q36953593 | Disparities in ovarian cancer care quality and survival according to race and socioeconomic status |
| Q40853433 | Disparities in survival by insurance status in patients with Hodgkin lymphoma |
| Q34138121 | Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. |
| Q39641702 | Disparities in the use of minimally invasive surgery for colorectal disease |
| Q37756335 | Do African American men have lower survival from prostate cancer compared with White men? A meta-analysis |
| Q36435618 | Do adverse histopathologic findings in colorectal cancer patients explain disparate outcomes? |
| Q36606170 | Does race have a place in biotechnological research? |
| Q40236850 | Dying to be Screened: Exploring the Unequal Burden of Head and Neck Cancer in Health Provider Shortage Areas |
| Q39852682 | Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population |
| Q34961124 | Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival: findings from the National Longitudinal Mortality Study, 1979-2003. |
| Q46585993 | Elevated expression of glutathione S-transferase pi and p53 confers poor prognosis in head and neck cancer patients treated with chemoradiotherapy but not radiotherapy alone |
| Q64917329 | Endocrine Therapy Nonadherence and Discontinuation in Black and White Women. |
| Q81073118 | Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival |
| Q38115726 | Erectile dysfunction after radiotherapy for prostate cancer: a model assessing the conflicting literature on dose-volume effects. |
| Q40499819 | Ethnic differences in breast cancer survival in New Zealand: contributions of differences in screening, treatment, tumor biology, demographics and comorbidities |
| Q44982280 | Ethnic differences in prostate cancer survival in New Zealand: a national study |
| Q46640458 | Ethnic/racial influences on the physiologic health of cancer survivors |
| Q35210082 | Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries |
| Q35744804 | Gender, racial and age differences in bladder cancer incidence and mortality. |
| Q39828575 | Geographic access to cancer care in the U.S. |
| Q57286596 | Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells |
| Q90746083 | Greater Survival Improvement in African American vs. Caucasian Women with Hormone Negative Breast Cancer |
| Q51948740 | Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. |
| Q37036339 | Health care utilization by adult Hispanic long-term survivors of hematopoietic stem cell transplantation: report from the Bone Marrow Transplant Survivor Study |
| Q35437586 | Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000-2010. |
| Q37288434 | High cancer-related mortality in an urban, predominantly African-American, HIV-infected population |
| Q39290822 | High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database |
| Q37310924 | Histopathologic differences account for racial disparity in uterine cancer survival |
| Q35713044 | History of Recreational Physical Activity and Survival After Breast Cancer: The California Breast Cancer Survivorship Consortium |
| Q46886278 | Hospice Utilization and End-of-Life Care Decision Making of African Americans |
| Q37324988 | Hospital factors and racial disparities in mortality after surgery for breast and colon cancer |
| Q55401345 | Identifying the Causes of Cancer Health Disparities: Biologic and Non Biologic Determinants. |
| Q33526534 | Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. |
| Q35210102 | Impact of patient navigation from diagnosis to treatment in an urban safety net breast cancer population |
| Q34017035 | Increased racial differences on breast cancer care and survival in America: historical evidence consistent with a health insurance hypothesis, 1975-2001 |
| Q35837820 | Innovative oral treatments of uterine leiomyoma |
| Q39764099 | Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database |
| Q35144499 | Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale |
| Q37152796 | Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis. |
| Q44975348 | Is race really a negative prognostic factor for cancer? |
| Q90850789 | Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival |
| Q37361918 | Life-Threatening Disparities: The Treatment of Black and White Cancer Patients |
| Q35847450 | Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer |
| Q24813726 | Long-term all-sites cancer mortality time trends in Ohio, USA, 1970-2001: differences by race, gender and age |
| Q43793910 | Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status |
| Q39750199 | Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. |
| Q38720804 | Lung Adenocarcinoma Survival in EGFR-Mutated African-Caribbean Patients: A Multicenter Study in the French West Indies. |
| Q53177073 | Lung Cancer Health Disparities. |
| Q55242701 | Lung cancer early detection and health disparities: the intersection of epigenetics and ethnicity. |
| Q37415232 | Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. |
| Q26824379 | Medical treatment of uterine leiomyoma |
| Q36800052 | Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer |
| Q35807962 | Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian women |
| Q40007749 | Minority Use of a National Cancer Institute-Designated Comprehensive Cancer Center and Non-specialty Hospitals in Two Florida Regions |
| Q38455272 | Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). |
| Q34228266 | Molecular genetics and racial disparities of uterine leiomyomas |
| Q46749496 | Molecular profiling of endometrial cancers from African-American and Caucasian women |
| Q60308253 | Nonverbal synchrony as a behavioural marker of patient and physician race-related attitudes and a predictor of outcomes in oncology interactions: protocol for a secondary analysis of video-recorded cancer treatment discussions |
| Q44641465 | Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups |
| Q53013035 | Outcomes and Prognostic Factors of Primary Urethral Cancer. |
| Q35128439 | Outcomes research in oncology: improving patients' experiences with cancer treatment |
| Q91296449 | Pan-cancer clinical and molecular analysis of racial disparities |
| Q34985926 | Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma |
| Q89102964 | Patient HLA Germline Variation and Transplant Survivorship |
| Q35771316 | Perceptions of Cancer Clinical Research Among African American Men in North Carolina |
| Q52586857 | Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making. |
| Q39773084 | Physician perspectives on end-of-life care: factors of race, specialty, and geography |
| Q37828119 | Pigment epithelium-derived factor as an impending therapeutic agent against vascular epithelial growth factor-driven tumor-angiogenesis. |
| Q48181029 | Population-based cancer survival (2001 to 2009) in the United States: Findings from the CONCORD-2 study. |
| Q51032163 | Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity. |
| Q47610558 | Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy |
| Q34504603 | Prognostic significance of mucinous differentiation of endometrioid adenocarcinoma of the endometrium |
| Q35433274 | Prostate cancer incidence and mortality in barbados, west indies |
| Q64109725 | QOL and Survival Comparisons by Race in Oncology Clinical Trials |
| Q39649193 | Qualitative research-enhanced understanding of patients' beliefs: Results of focus groups with low-income, urban, African American adults with asthma |
| Q35809136 | Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial |
| Q33708469 | Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma |
| Q59187840 | Race and surgical mortality in the United States |
| Q37245950 | Race disparities attributed to volumetric tumor burden in patients with head and neck cancer treated with radiotherapy. |
| Q35751900 | Race versus place of service in mortality among medicare beneficiaries with cancer |
| Q35568229 | Race, response to chemotherapy, and outcome within clinical breast cancer subtypes |
| Q90108136 | Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA |
| Q38268346 | Racial Disparity Among the Head and Neck Cancer Population |
| Q88959713 | Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma |
| Q47883236 | Racial and ethnic disparities in a national cohort of ampullary cancer patients |
| Q88235283 | Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies |
| Q41394946 | Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites |
| Q36440803 | Racial differences in oncogene mutations detected in early-stage low-grade endometrial cancers |
| Q37474066 | Racial differences in predictors of intensive end-of-life care in patients with advanced cancer |
| Q46830980 | Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study |
| Q46786327 | Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States |
| Q33596176 | Racial differences in treatment and outcomes among patients with early stage bladder cancer |
| Q83568221 | Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis |
| Q44588876 | Racial disparities and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients |
| Q83320720 | Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time |
| Q36503071 | Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? |
| Q34541680 | Racial disparities in incidence and outcome in multiple myeloma: a population-based study |
| Q39096126 | Racial disparities in operative outcomes after major cancer surgery in the United States |
| Q35016815 | Racial disparities in outcomes following PEA and asystole in-hospital cardiac arrests |
| Q37834746 | Racial disparities in ovarian cancer surgical care: a population-based analysis |
| Q47549613 | Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014. |
| Q82406002 | Racial disparities in resource utilization for cystectomy |
| Q35991466 | Racial disparities in surgical resection and survival among elderly patients with poor prognosis cancer |
| Q44740342 | Racial disparities in survival after diagnosis of prostate cancer in Kentucky, 2001-2010. |
| Q75238086 | Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries |
| Q55078257 | Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes. |
| Q82539011 | Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort |
| Q36572824 | Racial segregation and disparities in cancer stage for seniors |
| Q35693282 | Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients |
| Q37476861 | Racial, ethnic and socioeconomic disparities in the treatment of brain tumors |
| Q45728613 | Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988-2004. |
| Q37130130 | Racial/Ethnic Disparities in Survival Among Patients With Young-Onset Colorectal Cancer |
| Q40566372 | Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter? |
| Q36421159 | Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer |
| Q46347653 | Racial/ethnic differences in survival among elderly patients with a primary glioblastoma. |
| Q93265730 | Racial/ethnic disparities in penile squamous cell carcinoma incidences, clinical characteristics, and outcomes: A population-based study, 2004-2016 |
| Q35011186 | Receipt of general medical care by colorectal cancer patients: a longitudinal study |
| Q36067697 | Recruitment and retention results for a population-based cervical cancer biobehavioral clinical trial |
| Q50118315 | Risk Factors for Adverse Events in Patients With Breast, Colorectal, and Lung Cancer |
| Q58536084 | Role of Race and Ethnicity Predictive Modeling and Spatial Analysis in Addressing Health Disparities |
| Q55155677 | Smoking, depression, and hospital costs of respiratory cancers: Examining race and sex variation. |
| Q102328343 | Social needs and health-related quality of life among African American cancer survivors: Results from the Detroit Research on Cancer Survivors study |
| Q39905382 | Social workers as patient navigators for breast cancer survivors: what do African-American medically underserved women think of this idea? |
| Q35941428 | Socioeconomic and Other Demographic Disparities Predicting Survival among Head and Neck Cancer Patients |
| Q41705154 | Socioeconomic and sociodemographic predictors of cancer-related information sources used by cancer survivors |
| Q33718809 | Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era. |
| Q46126929 | Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study |
| Q53676277 | Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. |
| Q30383333 | Socioeconomic status does not affect prognosis in patients with glioblastoma multiforme. |
| Q31061210 | Some thoughts on health surveillance data, race, and population categorization |
| Q37007673 | Story of Stone Soup: a recipe to improve health disparities. |
| Q35640117 | Survival of U.S. Black and White patients with squamous cell cancer of the esophagus. |
| Q81253030 | Systemic treatment of colorectal cancer |
| Q82416307 | Targeted Intervention Strategies to Increase and Maintain Mammography Utilization Among African American Women |
| Q40001465 | Teaching 'race' at medical school: social scientists on the margin |
| Q79319720 | Telephone outreach to increase colorectal cancer screening in an urban minority population |
| Q44228246 | Testicular cancer patterns in African-American men. |
| Q46362551 | Testicular cancer patterns in Asian-American males: an opportunity for public health education to impact outcomes |
| Q64101397 | The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS) |
| Q33716455 | The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival |
| Q97885862 | The Contribution of Race to Breast Tumor Microenvironment Composition and Disease Progression |
| Q37059764 | The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality |
| Q38396110 | The Influence of Race on Overall Survival in Patients with Newly Diagnosed Bladder Cancer |
| Q58799382 | The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD |
| Q46979874 | The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer |
| Q37850052 | The impact of race on survival in uterine serous carcinoma: a hospital-based study |
| Q37238549 | The influence of limited English proficiency on outcome in patients treated with radiotherapy for head and neck cancer |
| Q30359490 | The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study. |
| Q37272980 | The role of tobacco in cancer health disparities. |
| Q36158077 | The role of unconscious bias in surgical safety and outcomes |
| Q37014254 | Toward the Elimination of Colorectal Cancer Disparities Among African Americans |
| Q46673940 | Trends in Survival Rates After Allogeneic Hematopoietic Stem-Cell Transplantation for Acute and Chronic Leukemia by Ethnicity in the United States and Canada |
| Q40811104 | Trends in Testicular Cancer Survival: A Large Population-based Analysis |
| Q55512863 | Two countries divided by a common language: health systems in the UK and USA. |
| Q37393760 | Uncovering disparities in survival after non-small-cell lung cancer among Asian/Pacific Islander ethnic populations in California |
| Q84463431 | Understanding social obstacles to early breast cancer detection is critical to improving breast cancer outcome in low- and middle-resource countries |
| Q46550043 | Unequal burden of head and neck cancer in the United States |
| Q34639294 | United states acculturation and cancer patients' end-of-life care |
| Q46232535 | Using navigators to improve care of underserved patients: current practices and approaches |
| Q36494003 | Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment |
| Q34337189 | Variations among Institutional Review Board reviews in a multisite health services research study |
| Q35015410 | Variations in gastric cancer care: a trend beyond racial disparities |
Search more.